Clinical Trial Update: A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation [NA]

View source ↗

Summary

The trial is a prospective single-arm, open-label study evaluating the FARAPULSE Pulsed Field Ablation System in patients with persistent atrial fibrillation, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2025-10-24